What occurs if at cell binds to an antigen and the T cell does not receive a co stimulatory signal?

1. Bretscher P, Cohn M: A theory of self-nonself discrimination. Science (New York). 1970, 169: 1042-1049.

   Article  CAS  Google Scholar 

2. Lafferty KJ, Misko IS, Cooley MA: Allogeneic stimulation modulates the in vitro response of T cells to transplantation antigen. Nature. 1974, 249: 275-276.

   Article  CAS  PubMed  Google Scholar 

3. Jenkins MK, Schwartz RH: Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med. 1987, 165: 302-319.

   Article  CAS  PubMed  Google Scholar 

4. Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol. 1994, 12: 991-1045.

   Article  CAS  PubMed  Google Scholar 

5. Janeway CA, Medzhitov R: Innate immune recognition. Annu Rev Immunol. 2002, 20: 197-216.

   Article  CAS  PubMed  Google Scholar 

6. Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol. 1996, 14: 233-258.

   Article  CAS  PubMed  Google Scholar 

7. Sharpe AH, Freeman GJ: The B7-CD28 superfamily. Nat Rev. 2002, 2: 116-126.

   CAS  Google Scholar 

8. Kremer JM, Genant HK, Moreland LW, Russell AS, Emery P, Abud-Mendoza C, Szechinski J, Li T, Ge Z, Becker JC, Westhovens R: Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial. Ann Intern Med. 2006, 144: 865-876.

   Article  CAS  PubMed  Google Scholar 

9. Weaver TA, Charafeddine AH, Kirk AD: Costimulation blockade: towards clinical application. Front Biosci. 2008, 13: 2120-2139.

   Article  CAS  PubMed  Google Scholar 

10. Leibson PJ: The regulation of lymphocyte activation by inhibitory receptors. Curr Opin Immunol. 2004, 16: 328-336.

    Article  CAS  PubMed  Google Scholar 

11. Keir ME, Francisco LM, Sharpe AH: PD-1 and its ligands in T-cell immunity. Curr Opin Immunol. 2007, 19: 309-314.

    Article  CAS  PubMed  Google Scholar 

12. Murphy KM, Nelson CA, Sedy JR: Balancing co-stimulation and inhibition with BTLA and HVEM. Nat Rev. 2006, 6: 671-681.

    CAS  Google Scholar 

13. Lucas PJ, Negishi I, Nakayama K, Fields LE, Loh DY: Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J Immunol. 1995, 154: 5757-5768.

    CAS  PubMed  Google Scholar 

14. O'Neill SK, Cao Y, Hamel KM, Doodes PD, Hutas G, Finnegan A: Expression of CD80/86 on B cells is essential for autoreactive T cell activation and the development of arthritis. J Immunol. 2007, 179: 5109-5116.

    Article  PubMed  Google Scholar 

15. Ferguson SE, Han S, Kelsoe G, Thompson CB: CD28 is required for germinal center formation. J Immunol. 1996, 156: 4576-4581.

    CAS  PubMed  Google Scholar 

16. Green JM, Noel PJ, Sperling AI, Walunas TL, Gray GS, Bluestone JA, Thompson CB: Absence of B7-dependent responses in CD28-deficient mice. Immunity. 1994, 1: 501-508.

    Article  CAS  PubMed  Google Scholar 

17. Shahinian A, Pfeffer K, Lee KP, Kundig TM, Kishihara K, Wakeham A, Kawai K, Ohashi PS, Thompson CB, Mak TW: Differential T cell costimulatory requirements in CD28-deficient mice. Science (New York). 1993, 261: 609-612.

    Article  CAS  Google Scholar 

18. Vallejo AN: CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev. 2005, 205: 158-169.

    Article  CAS  PubMed  Google Scholar 

19. Bryl E, Vallejo AN, Weyand CM, Goronzy JJ: Down-regulation of CD28 expression by TNF-alpha. J Immunol. 2001, 167: 3231-3238.

    Article  CAS  PubMed  Google Scholar 

20. Greenwald RJ, Freeman GJ, Sharpe AH: The B7 family revisited. Annu Rev Immunol. 2005, 23: 515-548.

    Article  PubMed  Google Scholar 

21. McAdam AJ, Schweitzer AN, Sharpe AH: The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+T cells. Immunol Rev. 1998, 165: 231-247.

    Article  CAS  PubMed  Google Scholar 

22. van Essen D, Kikutani H, Gray D: CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature. 1995, 378: 620-623.

    Article  CAS  PubMed  Google Scholar 

23. Acuto O, Michel F: CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat Rev. 2003, 3: 939-951.

    CAS  Google Scholar 

24. Kane LP, Lin J, Weiss A: It's all Relative: NF-kappaB and CD28 costimulation of T-cell activation. Trends Immunol. 2002, 23: 413-420.

    Article  CAS  PubMed  Google Scholar 

25. Michel F, Mangino G, Attal-Bonnefoy G, Tuosto L, Alcover A, Roumier A, Olive D, Acuto O: CD28 utilizes Vav-1 to enhance TCR-proximal signaling and NF-AT activation. J Immunol. 2000, 165: 3820-3829.

    Article  CAS  PubMed  Google Scholar 

26. Rincon M, Flavell RA: AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J. 1994, 13: 4370-4381.

    PubMed Central  CAS  PubMed  Google Scholar 

27. Michel F, Attal-Bonnefoy G, Mangino G, Mise-Omata S, Acuto O: CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. Immunity. 2001, 15: 935-945.

    Article  CAS  PubMed  Google Scholar 

28. Viola A, Lanzavecchia A: T cell activation determined by T cell receptor number and tunable thresholds. Science (New York). 1996, 273: 104-106.

    Article  CAS  Google Scholar 

29. Riley JL, Mao M, Kobayashi S, Biery M, Burchard J, Cavet G, Gregson BP, June CH, Linsley PS: Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc Natl Acad Sci USA. 2002, 99: 11790-11795.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

30. Lühder F, Huang Y, Dennehy KM, Guntermann C, Müller I, Winkler E, Kerkau T, Ikemizu S, Davis SJ, Hanke T, Hünig T: Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists. J Exp Med. 2003, 197: 955-966.

    Article  PubMed Central  PubMed  Google Scholar 

31. Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, Panoskaltsis N: Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med. 2006, 355: 1018-1028.

    Article  CAS  PubMed  Google Scholar 

32. Kane LP, Weiss A: The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunol Rev. 2003, 192: 7-20.

    Article  CAS  PubMed  Google Scholar 

33. Parry RV, Riley JL, Ward SG: Signalling to suit function: tailoring phosphoinositide 3-kinase during T-cell activation. Trends Immunol. 2007, 28: 161-168.

    Article  CAS  PubMed  Google Scholar 

34. Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL: Tec family kinases in T lymphocyte development and function. Annu Rev Immunol. 2005, 23: 549-600.

    Article  CAS  PubMed  Google Scholar 

35. Appleman LJ, Berezovskaya A, Grass I, Boussiotis VA: CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J Immunol. 2000, 164: 144-151.

    Article  CAS  PubMed  Google Scholar 

36. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, Lindsten T, Thompson CB: CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity. 1995, 3: 87-98.

    Article  CAS  PubMed  Google Scholar 

37. Borowski AB, Boesteanu AC, Mueller YM, Carafides C, Topham DJ, Altman JD, Jennings SR, Katsikis PD: Memory CD8+ T cells require CD28 costimulation. J Immunol. 2007, 179: 6494-6503.

    Article  CAS  PubMed  Google Scholar 

38. Fuse S, Zhang W, Usherwood EJ: Control of memory CD8+T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response. J Immunol. 2008, 180: 1148-1157.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

39. Tay L, Leon F, Vratsanos G, Raymond R, Corbo M: Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: a randomized, open-label, parallel group study in healthy subjects. Arthritis Res Ther. 2007, 9: R38-

    Article  PubMed Central  PubMed  Google Scholar 

40. Donahue JG, Choo PW, Manson JE, Platt R: The incidence of herpes zoster. Arch Intern Med. 1995, 155: 1605-1609.

    Article  CAS  PubMed  Google Scholar 

41. Vanderlugt CL, Miller SD: Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev. 2002, 2: 85-95.

    CAS  Google Scholar 

42. Goronzy JJ, Weyand CM: Rheumatoid arthritis. Immunol Rev. 2005, 204: 55-73.

    Article  CAS  PubMed  Google Scholar 

43. Watts TH: TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol. 2005, 23: 23-68.

    Article  CAS  PubMed  Google Scholar 

44. Hendriks J, Xiao Y, Borst J: CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J Exp Med. 2003, 198: 1369-1380.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

45. Lens SM, Tesselaar K, van Oers MH, van Lier RA: Control of lymphocyte function through CD27-CD70 interactions. Semin Immunol. 1998, 10: 491-499.

    Article  CAS  PubMed  Google Scholar 

46. Arens R, Tesselaar K, Baars PA, van Schijndel GM, Hendriks J, Pals ST, Krimpenfort P, Borst J, van Oers MH, van Lier RA: Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity. 2001, 15: 801-812.

    Article  CAS  PubMed  Google Scholar 

47. Nakajima A, Oshima H, Nohara C, Morimoto S, Yoshino S, Kobata T, Yagita H, Okumura K: Involvement of CD70-CD27 interactions in the induction of experimental autoimmune encephalomyelitis. J Neuroimmunol. 2000, 109: 188-196.

    Article  CAS  PubMed  Google Scholar 

48. Tesselaar K, Arens R, van Schijndel GM, Baars PA, Valk van der MA, Borst J, van Oers MH, van Lier RA: Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions. Nat Immunol. 2003, 4: 49-54.

    Article  CAS  PubMed  Google Scholar 

49. Lu Q, Wu A, Richardson BC: Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J Immunol. 2005, 174: 6212-6219.

    Article  CAS  PubMed  Google Scholar 

50. Lee WW, Yang ZZ, Li G, Weyand CM, Goronzy JJ: Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis. J Immunol. 2007, 179: 2609-2615.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

51. Grewal IS, Flavell RA: CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol. 1998, 16: 111-135.

    Article  CAS  PubMed  Google Scholar 

52. Kang YM, Zhang X, Wagner UG, Yang H, Beckenbaugh RD, Kurtin PJ, Goronzy JJ, Weyand CM: CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J Exp Med. 2002, 195: 1325-1336.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

53. Ridge JP, Di Rosa F, Matzinger P: A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature. 1998, 393: 474-478.

    Article  CAS  PubMed  Google Scholar 

54. Schoenberger SP, Toes RE, Voort van der EI, Offringa R, Melief CJ: T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 1998, 393: 480-483.

    Article  CAS  PubMed  Google Scholar 

55. Yazdany J, Davis J: The role of CD40 ligand in systemic lupus erythematosus. Lupus. 2004, 13: 377-380.

    Article  CAS  PubMed  Google Scholar 

56. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998, 391: 591-594.

    Article  CAS  PubMed  Google Scholar 

57. Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD: CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med. 2002, 8: 247-252.

    Article  CAS  PubMed  Google Scholar 

58. Kroczek RA, Mages HW, Hutloff A: Emerging paradigms of T-cell co-stimulation. Curr Opin Immunol. 2004, 16: 321-327.

    Article  CAS  PubMed  Google Scholar 

59. Suh WK, Tafuri A, Berg-Brown NN, Shahinian A, Plyte S, Duncan GS, Okada H, Wakeham A, Odermatt B, Ohashi PS, Mak TW: The inducible costimulator plays the major costimulatory role in humoral immune responses in the absence of CD28. J Immunol. 2004, 172: 5917-5923.

    Article  CAS  PubMed  Google Scholar 

60. Coyle AJ, Lehar S, Lloyd C, Tian J, Delaney T, Manning S, Nguyen T, Burwell T, Schneider H, Gonzalo JA, Gosselin M, Owen LR, Rudd CE, Gutierrez-Ramos JC: The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity. 2000, 13: 95-105.

    Article  CAS  PubMed  Google Scholar 

61. Loke P, Allison JP: Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cells. Arthritis Res Ther. 2004, 6: 208-214.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

62. Nurieva RI, Treuting P, Duong J, Flavell RA, Dong C: Inducible costimulator is essential for collagen-induced arthritis. J Clin Invest. 2003, 111: 701-706.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

63. Rottman JB, Smith T, Tonra JR, Ganley K, Bloom T, Silva R, Pierce B, Gutierrez-Ramos JC, Ozkaynak E, Coyle AJ: The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat Immunol. 2001, 2: 605-611.

    Article  CAS  PubMed  Google Scholar 

64. Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K, Chen L: B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol. 2001, 2: 269-274.

    Article  CAS  PubMed  Google Scholar 

65. Higgins LM, McDonald SA, Whittle N, Crockett N, Shields JG, MacDonald TT: Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J Immunol. 1999, 162: 486-493.

    CAS  PubMed  Google Scholar 

66. Malmstrom V, Shipton D, Singh B, Al-Shamkhani A, Puklavec MJ, Barclay AN, Powrie F: CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. J Immunol. 2001, 166: 6972-6981.

    Article  CAS  PubMed  Google Scholar 

67. Ndhlovu LC, Ishii N, Murata K, Sato T, Sugamura K: Critical involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis. J Immunol. 2001, 167: 2991-2999.

    Article  CAS  PubMed  Google Scholar 

68. Weinberg AD, Wegmann KW, Funatake C, Whitham RH: Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. J Immunol. 1999, 162: 1818-1826.

    CAS  PubMed  Google Scholar 

69. Yoshioka T, Nakajima A, Akiba H, Ishiwata T, Asano G, Yoshino S, Yagita H, Okumura K: Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis. Eur J Immunol. 2000, 30: 2815-2823.

    Article  CAS  PubMed  Google Scholar 

70. Mittler RS, Foell J, McCausland M, Strahotin S, Niu L, Bapat A, Hewes LB: Anti-CD137 antibodies in the treatment of autoimmune disease and cancer. Immunol Res. 2004, 29: 197-208.

    Article  CAS  PubMed  Google Scholar 

71. Myers LM, Vella AT: Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation. Trends Immunol. 2005, 26: 440-446.

    Article  CAS  PubMed  Google Scholar 

72. Lyons PA, Hancock WW, Denny P, Lord CJ, Hill NJ, Armitage N, Siegmund T, Todd JA, Phillips MS, Hess JF, Chen SL, Fischer PA, Peterson LB, Wicker LS: The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity. 2000, 13: 107-115.

    Article  CAS  PubMed  Google Scholar 

73. Vivier E, Anfossi N: Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev. 2004, 4: 190-198.

    CAS  Google Scholar 

74. Young NT, Uhrberg M, Phillips JH, Lanier LL, Parham P: Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J Immunol. 2001, 166: 3933-3941.

    Article  CAS  PubMed  Google Scholar 

75. Czesnikiewicz-Guzik M, Lee WW, Cui D, Hiruma Y, Lamar DL, Yang ZZ, Ouslander JG, Weyand CM, Goronzy JJ: T cell subset-specific susceptibility to aging. Clin Immunol (Orlando, FL). 2008, 127: 107-118.

    Article  CAS  Google Scholar 

76. Henel G, Singh K, Cui D, Pryshchep S, Lee WW, Weyand CM, Goronzy JJ: Uncoupling of T-cell effector functions by inhibitory killer immunoglobulin-like receptors. Blood. 2006, 107: 4449-4457.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

77. Snyder MR, Weyand CM, Goronzy JJ: The double life of NK receptors: stimulation or co-stimulation?. Trends Immunol. 2004, 25: 25-32.

    Article  CAS  PubMed  Google Scholar 

78. Humphrey MB, Lanier LL, Nakamura MC: Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol Rev. 2005, 208: 50-65.

    Article  CAS  PubMed  Google Scholar 

79. Snyder MR, Nakajima T, Leibson PJ, Weyand CM, Goronzy JJ: Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms. J Immunol. 2004, 173: 3725-3731.

    Article  CAS  PubMed  Google Scholar 

80. Snyder MR, Lucas M, Vivier E, Weyand CM, Goronzy JJ: Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells. J Exp Med. 2003, 197: 437-449.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

81. Rajagopalan S, Long EO: Understanding how combinations of HLA and KIR genes influence disease. J Exp Med. 2005, 201: 1025-1029.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

82. Yen JH, Moore BE, Nakajima T, Scholl D, Schaid DJ, Weyand CM, Goronzy JJ: Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med. 2001, 193: 1159-1167.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

83. Reinhold MI, Lindberg FP, Kersh GJ, Allen PM, Brown EJ: Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway. J Exp Med. 1997, 185: 1-11.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

84. Park YW, Kang YM, Butterfield J, Detmar M, Goronzy JJ, Weyand CM: Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis. Am J Pathol. 2004, 165: 2087-2098.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

85. Vallejo AN, Mugge LO, Klimiuk PA, Weyand CM, Goronzy JJ: Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells. J Immunol. 2000, 164: 2947-2954.

    Article  CAS  PubMed  Google Scholar 

86. Vallejo AN, Yang H, Klimiuk PA, Weyand CM, Goronzy JJ: Synoviocyte-mediated expansion of inflammatory T cells in rheumatoid synovitis is dependent on CD47-thrombospondin 1 interaction. J Immunol. 2003, 171: 1732-1740.

    Article  CAS  PubMed  Google Scholar 

87. Gonzalez S, Groh V, Spies T: Immunobiology of human NKG2D and its ligands. Curr Topics Microbiol Immunol. 2006, 298: 121-138.

    CAS  Google Scholar 

88. Goronzy JJ, Henel G, Sawai H, Singh K, Lee EB, Pryshchep S, Weyand CM: Costimulatory pathways in rheumatoid synovitis and T-cell senescence. Ann N Y Acad Sci. 2005, 1062: 182-194.

    Article  CAS  PubMed  Google Scholar 

89. Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T: Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci USA. 2003, 100: 9452-9457.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

90. Upshaw JL, Leibson PJ: NKG2D-mediated activation of cytotoxic lymphocytes: unique signaling pathways and distinct functional outcomes. Semin Immunol. 2006, 18: 167-175.

    Article  CAS  PubMed  Google Scholar 

91. Sawai H, Park YW, Roberson J, Imai T, Goronzy JJ, Weyand CM: T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis. Arthritis Rheum. 2005, 52: 1392-1401.

    Article  CAS  PubMed  Google Scholar 

92. Sawai H, Park YW, He X, Goronzy JJ, Weyand CM: Fractalkine mediates T cell-dependent proliferation of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheum. 2007, 56: 3215-3225.

    Article  CAS  PubMed  Google Scholar 

Page 2

Co-stimulatory receptor-ligand pairs in the initiation of a T-cell response. CD27 and CD28 are co-stimulatory molecules that are constitutively expressed. Their ligands CD70, CD80, and CD86 are inducible on dendritic cells upon their activation. The CD154-CD40 interaction represents an important amplification loop that upregulates the expression of CD80 and CD86. MHC, major histocompatibility complex; TCR, T-cell receptor.